Modulation of Synovial Fluid-Derived Mesenchymal Stem Cells by Intra-Articular and Intraosseous Platelet Rich Plasma Administration

Table 1

Patients included in the study and their clinical OA grade.

	IA group	IO group
Age (mean ± SD)	62.6 ± 11.8	63.6 ± 11.2
Age range	41–77	41–80
OA grade II (%)	50	29.4
OA grade III (%)	35.7	47.1
OA grade IV (%)	14.3	23.5